Cellectis Launches Ectycell Subsidiary Dedicated to Stem Cells Applications
05-Oct-2009 -
Cellectis S.A. has announced the incorporation of Ectycell, a subsidiary dedicated to the biomedical uses of stem cells. The initial applications developed are (i) tools for generating induced pluripotent stem cells from adult cells, (ii) robust, reproducible differentiation of stem cells and ...
drug development
Parkinson's disease
pluripotent stem cells
+1